Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Chambers

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Frontiers in Cellular and Infection Microbiology|September 2, 2017
Extensive Metabolic Remodeling Differentiates Non-pathogenic and Pathogenic Growth Forms of the Dimorphic Pathogen <i>Talaromyces marneffei</i>Shivani Pasricha, James I MacRae, Hwa H Chua, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 27, 2025
Characteristics associated with alterations in pruritus severity across gestation in intrahepatic cholestasis of pregnancy: a longitudinal cohort studyXi Yang, Nicholas J Williamson, Jenna Sajous, et al.
Obstetric Medicine|December 1, 2025
Impact of pruritus in patients at high risk of significant intrahepatic cholestasis of pregnancyCatherine Williamson, Jenny Chambers, Caroline Ovadia, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 31, 2025
Stillbirth in intrahepatic cholestasis of pregnancy and timing of severely elevated bile acid concentrations: an observational cohort studyAgata Majewska, Paul T Seed, Jenny Chambers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 14, 2017
Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal sizeGeorgia Papacleovoulou, Vanya Nikolova, Olayiwola Oduwole, et al.
Progress in Biophysics and Molecular Biology|January 19, 2016
The protective effect of ursodeoxycholic acid in an in vitro model of the human fetal heart occurs via targeting cardiac fibroblastsFrancisca Schultz, Alveera Hasan, Anita Alvarez-Laviada, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 13, 2015
Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancyVictoria Geenes, Jenny Chambers, Rshmi Khurana, et al.
Obstetric Medicine|December 12, 2025
Determining and predicting biochemical disease trajectory in intrahepatic cholestasis of pregnancy: A longitudinal cohort studyNicholas J Williamson, Jenna Sajous, Tim Im Korevaar, et al.
Diabetes Care|December 16, 2014
The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growthMarcus G Martineau, Christina Raker, Peter H Dixon, et al.
Plos One|January 15, 2014
The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acidVictoria Geenes, Anita Lövgren-Sandblom, Lisbet Benthin, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Cellular and Infection Microbiology|September 2, 2017
Extensive Metabolic Remodeling Differentiates Non-pathogenic and Pathogenic Growth Forms of the Dimorphic Pathogen <i>Talaromyces marneffei</i>Shivani Pasricha, James I MacRae, Hwa H Chua, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 27, 2025
Characteristics associated with alterations in pruritus severity across gestation in intrahepatic cholestasis of pregnancy: a longitudinal cohort studyXi Yang, Nicholas J Williamson, Jenna Sajous, et al.
Obstetric Medicine|December 1, 2025
Impact of pruritus in patients at high risk of significant intrahepatic cholestasis of pregnancyCatherine Williamson, Jenny Chambers, Caroline Ovadia, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 31, 2025
Stillbirth in intrahepatic cholestasis of pregnancy and timing of severely elevated bile acid concentrations: an observational cohort studyAgata Majewska, Paul T Seed, Jenny Chambers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 14, 2017
Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal sizeGeorgia Papacleovoulou, Vanya Nikolova, Olayiwola Oduwole, et al.
Progress in Biophysics and Molecular Biology|January 19, 2016
The protective effect of ursodeoxycholic acid in an in vitro model of the human fetal heart occurs via targeting cardiac fibroblastsFrancisca Schultz, Alveera Hasan, Anita Alvarez-Laviada, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 13, 2015
Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancyVictoria Geenes, Jenny Chambers, Rshmi Khurana, et al.
Obstetric Medicine|December 12, 2025
Determining and predicting biochemical disease trajectory in intrahepatic cholestasis of pregnancy: A longitudinal cohort studyNicholas J Williamson, Jenna Sajous, Tim Im Korevaar, et al.
Diabetes Care|December 16, 2014
The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growthMarcus G Martineau, Christina Raker, Peter H Dixon, et al.
Plos One|January 15, 2014
The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acidVictoria Geenes, Anita Lövgren-Sandblom, Lisbet Benthin, et al.
Pageof 5